Prenetics Global Limited
Organization details
- Legal name
- Prenetics Global Limited
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Quarry Bay
- Headquarters country
- Hong Kong
- Fiscal year end
- December
- Ticker symbol
- PRE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001876431
Board of directors
-
Caroline S. Levy · DirectorSince 2026
-
Danny Sheng Wu Yeung · Director · Chief Executive OfficerSince 2026
-
Darshan Ravindra Shah · DirectorSince 2026
-
David Vanderveen · DirectorSince 2026
-
Hudson Blake Leogrande · DirectorSince 2026
-
Yin Pan Cheng · DirectorSince 2026
Chief executives
Board connections
1 of this board's directors also sit on 1 other board.
- via Caroline S. Levy
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $999,698
- 5 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Hudson Blake Leogrande Director | Option exercise | +2,000 | — | — |
| Oct 4, 2026 | Hudson Blake Leogrande Director | Option exercise | +2,000 | — | — |
| Sep 30, 2026 | Lo Hoi Chun Officer (Chief Financial Officer) | Option exercise | +7,635 | — | — |
| Sep 4, 2026 | Hudson Blake Leogrande Director | Option exercise | +2,000 | — | — |
| Aug 25, 2026 | Rosin Brian J Officer (CFO of IM8 (US) LLC) | Open-market purchase | +5,100 | $22.80 | $116,280 |
| Aug 24, 2026 | Rosin Brian J Officer (CFO of IM8 (US) LLC) | Open-market purchase | +18,000 | $21.19 | $381,420 |
| Aug 24, 2026 | Danny Sheng Wu Yeung Director, Officer (Chief Executive Officer) | Open-market purchase | +6,000 | $20.90 | $125,400 |
| Aug 24, 2026 | Danny Sheng Wu Yeung Director, Officer (Chief Executive Officer) | Open-market purchase | +11,181 | $21.40 | $239,273 |
| Aug 21, 2026 | Lo Hoi Chun Officer (Chief Financial Officer) | Option exercise | +32,736 | — | — |
| Aug 21, 2026 | Lo Hoi Chun Officer (Chief Financial Officer) | Option exercise | +45,815 | — | — |
| Aug 20, 2026 | Danny Sheng Wu Yeung Director, Officer (Chief Executive Officer) | Option exercise | +53,953 | — | — |
| Aug 20, 2026 | Danny Sheng Wu Yeung Director, Officer (Chief Executive Officer) | Other | −49,912 | — | — |
| Aug 20, 2026 | Danny Sheng Wu Yeung Director, Officer (Chief Executive Officer) | Open-market purchase | +7,500 | $18.31 | $137,325 |
| Aug 4, 2026 | Hudson Blake Leogrande Director | Option exercise | +2,001 | — | — |
| Jul 4, 2026 | Hudson Blake Leogrande Director | Option exercise | +2,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Prenetics Global Limited
Who is the CEO of Prenetics Global Limited?
Danny Sheng Wu Yeung has been Prenetics Global Limited's Chief Executive Officer since March 2026.
How many directors are on Prenetics Global Limited's board?
Prenetics Global Limited's board has 6 directors: Caroline S. Levy, Danny Sheng Wu Yeung, Darshan Ravindra Shah, David Vanderveen, Hudson Blake Leogrande and Yin Pan Cheng.
Are Prenetics Global Limited insiders buying or selling shares?
Over the last 12 months, Prenetics Global Limited insiders bought $999,698 of shares in 5 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="prenetics-global-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.